News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,915 Results
Type
Article (46375)
Company Profile (301)
Press Release (671239)
Section
Business (209227)
Career Advice (2232)
Deals (36377)
Drug Delivery (107)
Drug Development (82633)
Employer Resources (177)
FDA (16322)
Job Trends (15247)
News (353267)
Policy (33241)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2592)
Accelerated approval (4)
Adcomms (25)
Allergies (82)
Alliances (51036)
ALS (90)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (120)
Approvals (16312)
Artificial intelligence (245)
Autoimmune disease (19)
Automation (14)
Bankruptcy (370)
Best Places to Work (11739)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (221)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (252)
Cancer (2057)
Cardiovascular disease (173)
Career advice (1850)
Career pathing (31)
CAR-T (151)
Cell therapy (426)
Cervical cancer (19)
Clinical research (66932)
Collaboration (810)
Compensation (462)
Complete response letters (24)
COVID-19 (2631)
CRISPR (40)
C-suite (222)
Cystic fibrosis (101)
Data (1989)
Decentralized trials (2)
Denatured (20)
Depression (44)
Diabetes (250)
Diagnostics (6406)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (115)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (87110)
Editorial (34)
Employer branding (21)
Employer resources (152)
Events (115628)
Executive appointments (665)
FDA (17453)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (716)
Gene editing (105)
Generative AI (21)
Gene therapy (308)
GLP-1 (721)
Government (4435)
Grass and pollen (4)
Guidances (49)
Healthcare (18964)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2766)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (89)
Interviews (356)
IPO (16826)
IRA (42)
Job creations (3933)
Job search strategy (1590)
Kidney cancer (10)
Labor market (34)
Layoffs (475)
Leadership (18)
Legal (8120)
Liver cancer (70)
Lung cancer (294)
Lymphoma (136)
Machine learning (4)
Management (61)
Manufacturing (284)
MASH (62)
Medical device (13387)
Medtech (13392)
Mergers & acquisitions (20019)
Metabolic disorders (657)
Multiple sclerosis (75)
NASH (18)
Neurodegenerative disease (91)
Neuropsychiatric disorders (28)
Neuroscience (1887)
NextGen: Class of 2025 (6678)
Non-profit (4524)
Northern California (2468)
Now hiring (38)
Obesity (354)
Opinion (246)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (78)
Parkinson's disease (138)
Partnered (21)
Patents (208)
Patient recruitment (95)
Peanut (47)
People (58823)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20952)
Phase II (29523)
Phase III (21872)
Pipeline (1077)
Podcasts (66)
Policy (120)
Postmarket research (2589)
Preclinical (8862)
Press Release (72)
Prostate cancer (94)
Psychedelics (35)
Radiopharmaceuticals (248)
Rare diseases (382)
Real estate (6318)
Recruiting (67)
Regulatory (22666)
Reports (46)
Research institute (2375)
Resumes & cover letters (376)
Rett syndrome (4)
RNA editing (4)
RSV (41)
Schizophrenia (68)
Series A (128)
Series B (84)
Service/supplier (14)
Sickle cell disease (55)
Southern California (2132)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3831)
State (2)
Stomach cancer (14)
Supply chain (61)
The Weekly (44)
United States (21628)
Vaccines (687)
Venture capitalists (39)
Webinars (12)
Weight loss (242)
Women's health (33)
Worklife (17)
Date
Today (143)
Last 7 days (721)
Last 30 days (2816)
Last 365 days (34364)
2025 (8361)
2024 (36030)
2023 (40731)
2022 (51925)
2021 (56413)
2020 (54744)
2019 (47190)
2018 (35626)
2017 (33214)
2016 (32649)
2015 (38523)
2014 (33888)
2013 (29015)
2012 (29513)
2011 (30184)
2010 (28234)
Location
Africa (801)
Alabama (49)
Alaska (7)
Arizona (227)
Arkansas (13)
Asia (40359)
Australia (6674)
California (5631)
Canada (1881)
China (494)
Colorado (250)
Connecticut (261)
Delaware (130)
Europe (86560)
Florida (829)
Georgia (194)
Idaho (57)
Illinois (526)
India (24)
Indiana (294)
Iowa (9)
Japan (145)
Kansas (104)
Kentucky (23)
Louisiana (7)
Maine (61)
Maryland (848)
Massachusetts (4275)
Michigan (210)
Minnesota (380)
Mississippi (2)
Missouri (77)
Montana (30)
Nebraska (26)
Nevada (57)
New Hampshire (63)
New Jersey (1620)
New Mexico (29)
New York (1618)
North Carolina (957)
North Dakota (7)
Northern California (2468)
Ohio (193)
Oklahoma (14)
Oregon (33)
Pennsylvania (1276)
Puerto Rico (9)
Rhode Island (26)
South America (1188)
South Carolina (18)
South Dakota (1)
Southern California (2132)
Tennessee (93)
Texas (840)
Utah (168)
Virginia (134)
Washington D.C. (57)
Washington State (523)
West Virginia (3)
Wisconsin (50)
717,915 Results for "shanghai henlius biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Shanghai Henlius Biotech, Inc. and Organon announced that the European Medicines Agency has validated the marketing authorization applications for HLX14, an investigational Prolia® and Xgeva® biosimilar.
May 24, 2024
·
7 min read
Press Releases
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
March 31, 2025
·
6 min read
Business
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
Sermonix Pharmaceuticals Inc. and Shanghai Henlius Biotech, Inc. (2696.HK), today announced a strategic collaboration agreement in which Henlius will receive exclusive rights to develop, manufacture and commercialize Sermonix’s lead investigational drug, lasofoxifene, in China.
January 10, 2024
·
9 min read
Business
Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India
Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited (“Intas”) for the development and commercialisation in Europe and India for several indications including ES-SCLC, and specific formulation of HANSIZHUANG (serplulimab injection), Henlius’ novel anti-PD-1 mAb.
October 27, 2023
·
10 min read
Press Releases
Palleon Pharmaceuticals and Henlius Collaborate to Advance Glycan Editing as a Treatment for Autoimmune Diseases
December 19, 2024
·
5 min read
Press Releases
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
February 6, 2025
·
7 min read
C-suite
Biotech a Bright Spot for Female Founders Amid DEI Pullback
A new Pitchbook report found $4.3 billion in funding to women-fronted biotech companies across 121 deals. The increase comes as sociopolitical headwinds slam into initiatives to support women and minorities.
March 6, 2025
·
2 min read
·
Annalee Armstrong
Business
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
HanchorBio Inc. and Shanghai Henlius Biotech, Inc. today announced that the two companies have entered into a strategic framework agreement for collaboration to combine HanchorBio’s protein engineering expertise and proprietary Fc-based designer biologics (FBDB™) technology platform with Henlius’ integrated product development and commercialization capabilities.
August 28, 2023
·
5 min read
Drug Development
OncoHost’s PROphet® Platform to Support Henlius US-Based Phase III Trial for Patients with Extensive-Stage Small Cell Lung Cancer
OncoHost today announced a collaboration with Hengenix Biotech, Inc. (Henlius USA), affiliated with Shanghai Henlius Biotech, Inc., a global biopharmaceutical company with the vision to offer high-quality, affordable, and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
October 3, 2023
·
5 min read
Business
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius’ novel anti-PD-1 mAb HANSIZHUANG in MENA
Shanghai Henlius Biotech, Inc. has entered into an exclusive license agreement with PT Kalbe Genexine Biologics, an Indonesian pharmaceutical company and a holding subsidiary to PT Kalbe Farma, Tbk, for the development and commercialisation of HANSIZHUANG as a treatment for two indications including ES-SCLC, Henlius’ novel anti-PD-1 mAb, in 12 Middle East and North African countries including Saudi Arabia, the United Arab Emirates, Egypt, Qatar, Jordan, Morocco, etc.
September 12, 2023
·
9 min read
1 of 71,792
Next